BG
Bellevue Group Portfolio holdings
AUM
$4.54B
This Quarter Return
-6.91%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$488M
AUM Growth
+$488M
(-12%)
Cap. Flow
-$19.4M
Cap. Flow
% of AUM
-3.97%
Top 10 Holdings %
Top 10 Hldgs %
32.78%
Holding
126
New
5
Increased
19
Reduced
36
Closed
4
Top Buys
| 1 |
Incyte
INCY
|
$5.96M |
| 2 |
BCR
CR Bard Inc.
BCR
|
$5.86M |
| 3 |
Danaher
DHR
|
$5.76M |
| 4 |
AKRX
Akorn, Inc.
AKRX
|
$4.54M |
| 5 |
Edwards Lifesciences
EW
|
$3.75M |
Top Sells
| 1 |
Cardinal Health
CAH
|
$6.78M |
| 2 |
Illumina
ILMN
|
$5.21M |
| 3 |
AMSG
Amsurg Corp
AMSG
|
$4.79M |
| 4 |
Stryker
SYK
|
$3.04M |
| 5 |
Cigna
CI
|
$2.93M |
Sector Composition
| 1 | Healthcare | 91.87% |
| 2 | Financials | 0.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
QGENF
51
DELISTED
QIAGEN NV
QGENF
| $2.56M | 0.53% |
91,500
| – | – |
|
52
DexCom
DXCM
$30.9B
| $2.45M | 0.5% |
+164,000
| New | +$2.45M |
|
53
Perrigo
PRGO
$3.21B
| $2.41M | 0.49% |
29,000
-13,700
| -32% | -$1.14M |
|
54
Alkermes
ALKS
$4.95B
| $2.36M | 0.48% |
42,500
-9,000
| -17% | -$500K |
|
|
NUVA
55
DELISTED
NuVasive, Inc.
NUVA
| $2.36M | 0.48% |
35,000
-25,000
| -42% | -$1.68M |
|
|
CYTO
56
DELISTED
Altamira Therapeutics Ltd. Common Shares 0.01 SF (Bermuda)
CYTO
| $2.32M | 0.48% |
27
| – | – |
|
57
Nektar Therapeutics
NKTR
$543M
| $2.28M | 0.47% |
12,400
| – | – |
|
|
SGEN
58
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.27M | 0.46% |
43,000
| – | – |
|
59
Thermo Fisher Scientific
TMO
$183B
| $2.26M | 0.46% |
16,000
| – | – |
|
60
Globus Medical
GMED
$7.94B
| $2.18M | 0.45% |
87,700
| – | – |
|
|
ENDP
61
DELISTED
Endo International plc
ENDP
| $2.04M | 0.42% |
124,000
-66,000
| -35% | -$1.09M |
|
|
AET
62
DELISTED
Aetna Inc
AET
| $2.03M | 0.42% |
16,400
| – | – |
|
63
Masimo
MASI
$7.43B
| $2.02M | 0.41% |
30,000
-40,000
| -57% | -$2.7M |
|
64
Prothena Corp
PRTA
$452M
| $2.02M | 0.41% |
41,000
| – | – |
|
65
Agios Pharmaceuticals
AGIO
$2.36B
| $1.88M | 0.38% |
45,000
| – | – |
|
|
ALR
66
DELISTED
Alere Inc
ALR
| $1.87M | 0.38% |
47,983
+17,983
| +60% | +$701K |
|
|
BLUE
67
DELISTED
bluebird bio
BLUE
| $1.79M | 0.37% |
2,239
| – | – |
|
68
HCA Healthcare
HCA
$95.4B
| $1.76M | 0.36% |
23,800
-7,400
| -24% | -$548K |
|
69
AngioDynamics
ANGO
$432M
| $1.72M | 0.35% |
101,700
-28,300
| -22% | -$478K |
|
70
MacroGenics
MGNX
$121M
| $1.7M | 0.35% |
83,000
| – | – |
|
|
NVDQ
71
DELISTED
Novadaq Technologies Inc.
NVDQ
| $1.63M | 0.33% |
230,000
| – | – |
|
72
Pfizer
PFE
$141B
| $1.62M | 0.33% |
52,700
| – | – |
|
73
Merck
MRK
$210B
| $1.62M | 0.33% |
28,820
-20,436
| -41% | -$1.15M |
|
|
XENT
74
DELISTED
Intersect ENT, Inc
XENT
| $1.57M | 0.32% |
130,000
-75,325
| -37% | -$911K |
|
|
RDUS
75
DELISTED
Radius Health, Inc.
RDUS
| $1.52M | 0.31% |
40,000
-21,000
| -34% | -$799K |
|